- Country: Belgium
- Summary: Supplying Trastuzumab and Rituximab for Intravenous Use
- BET Ref No: 106185033
- Deadline: 09 Sep 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 3603790.86
- Notice Type: Tender
- Document Ref. No.: 506474-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Supply of Trastuzumab and Rituximab for intravenous use
Supply of Trastuzumab 150 mg for intravenous use
Supply of Rituximab 100 mg and 500 mg for intravenous use
Doc Title: Supply of Trastuzumab and Rituximab for intravenous use
Contract Type: supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupplying Trastuzumab and Rituximab for Intravenous Use - Belgium Tender
The UZ LEUVEN, a Government sector organization in Belgium, has announced a new tender for Supplying Trastuzumab and Rituximab for Intravenous Use. This tender is published on BelgiumTenders under BET Ref No: 106185033 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-09-09.
The estimated tender value is EUR 3603790.86, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
